Alcohol consumption and plasminogen activator inhibitor type 1: The National Heart, Lung, and Blood Institute Family Heart Study

American Heart Journal

Volumn 139, Issue 4, 2000, Pages 704-709

  Djoussé, Luc ^a   Pankow, James S ^a   Arnett, Donna K ^b   Zhang, Yuqing ^a   Hong, Yuling ^a   Province, Michael A ^a   Ellison, R Curtis ^a  

^a NONE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL METABOLISM; CLINICAL TRIAL; CORONARY ARTERY DISEASE; FEMALE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SEX DIFFERENCE; STROKE;

EID: 0034079695     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90052-8     Document Type: Article

References (26)

1. 1. Hamsten A, Walldius G, Szamosi A, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction Lancet 1987;2:3-9.
2. 2. Cortellaro M, Cofrancesco E, Boschetti C, et al. Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients: a case-control study. Arterioscler Thromb 1993;13:1412-7.
3. 3. Held C, Hjemdahl P, Rehnqvist N, et al. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis study in Stockholm. Circulation 1997;95:2380-6.
4. 4. Paramo JA, Colucci M, Collen D, et al. Plasminogen activator inhibitor in the blood of patients with coronary artery disease. BMJ 1985; 291:573-4.
5. 5. Nilsson TK, Johnson O. The extrinsic fibrinolytic system in survivors of myocardial infarction. Thromb Res 1987;48:621-30.
6. 6. Olofsson BO, Dahlen G, Nilsson TK. Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur Heart J 1989;10:77-82.
7. 7. Korninger C, Jager R, Huber K, et al. Levels of plasminogen activator inhibitor in patients with angina pectoris. Klin Wochenschrift 1988;66(suppl XII):59-61.
8. 8. Hendriks HF, Veenstra J, Wierik EJ, et al. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. BMJ 1994; 308:1003-6.
9. 9. Dimmitt SB, Rackic V, Puddey IB, et al. The effects of alcohol on coagulation and fibrinolytic factors: a controlled trial. Blood Coagul Fibrinolysis 1998;9:39-45.
10. 10. Urano T, Kojima Y, Takahashi M, et al. Impaired fibrinolysis in hypertension and obesity due to high plasminogen activator inhibitor-1 level in plasma. Jpn J Physiol 1993;43:221-8.
11. 11. Iso H, Folsom AR, Koike KA, et al. Antigens of tissue plasminogen activator and plasminogen activator inhibitor-1: correlates in nonsmoking Japanese and Caucasian men and women. Thromb Haemost 1993;70:475-80.
12. 12. Marques-Vidal P, Cambou JP, Nicaud V, et al. Cardiovascular risk factors and alcohol consumption in France and Northern Ireland. Atherosclerosis 1995;115:225-32.
13. 13. Higgins M, Province M, Heiss G, et al. NHLBI Family Heart Study: objectives and design. Am J Epidemiol 1996;143:1219-28.
14. 14. de Clerck PJ, Alessi MC, Verstreken M, et al. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988;71:220-5.
15. 15. Stein AD, Shea S, Basch CE, et al. Consistency of the Willett semiquantitative food frequency questionnaire and 24-hour dietary recalls in estimating nutrient intakes of preschool children. Am J Epidemiol 1992;135:667-77.
16. 16. Rimm EB, Giovannucci EL, Stampfer MJ, et al. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-26.
17. 17. Juhan-Vague I, Alessi MC. Plasminogen activator inhibitor 1 and atherothrombosis. Thromb Haemost 1993;70:138-43.
18. 18. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
19. 19. SAS/STAT User's Guide. Version 6, 4th edition, vol 2. Cary, NC: SAS Institute, Inc; 1989. p. 1071-126.
20. 20. Aikens ML, Benza RL, Grenett HE, et al. Ethanol increases surface-localized fibrinolytic activity in cultured endothelial cells. Alcohol Clin Exp Res 1997;21:1471-8.
21. 21. Tran-Thang C, Fassel-Felley J, Prolong G, et al. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis. Thromb Haemost 1989; 62:651-3.
22. 22. Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991;338:464-8.
23. 23. Stampfer MJ, Colditz GA, Willett WC, et al. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988;319;267-73.
24. 24. Rimm EB. Alcohol consumption and coronary heart disease: good habits may be more important than just good wine. Am J Epidemiol 1996;143:1094-8.
25. 25. Kiechl S, Willeit J, Rungger G, et al. Alcohol consumption and atherosclerosis: what is the relation? Prospective results from the Bruneck Study. Stroke 1998;29:900-7.
26. 26. Sacco RL, Elkind M, Boden-Albala N, et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999; 281:53-60.